Condition

Gynecologic Cancer

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 84 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials84
Recruiting21
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

60 shown
Exercise Oncology Clinic Pilot Feasibility TrialNCT07765927 · 2026-08-03
RECRUITING
CARE Tool Study Aim 3NCT07296887 · 2026-04-08
RECRUITING
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)NCT07524114 · 2026-03-31
RECRUITING
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot TrialNCT07447050 · 2025-12-23
RECRUITING
The Florida ASCENT StudyNCT07042243 · 2025-12-05
RECRUITING
Pilot Observational Study of an Integrative Cure Stay ProgramNCT07398079 · 2025-10-06
RECRUITING
Guided Meditation During Radiation Therapy for Breast and Gynecological MalignanciesNCT07166042 · 2025-09-25
RECRUITING
Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer SurvivorsNCT07120100 · 2025-08-27
RECRUITING
Brodalumab in the Treatment of Immune-Related Adverse EventsNCT06673329 · 2025-03-11
RECRUITING
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialNCT06580002 · 2024-12-02
RECRUITING
Stress Management Intervention Among Breast and Gynecologic Cancer Patients in Viet NamNCT06398067 · 2024-11-05
RECRUITING
Predicting Cancer Risk With Digital and Molecular MarkersNCT06962670 · 2024-09-14
RECRUITING
A Study of GC203 TIL in Advanced Malignant Solid TumorsNCT06375187 · 2024-05-29
RECRUITING
Web-Based Application for Monitoring Radiation Therapy Complications in Cancer PatientsNCT07416630 · 2023-09-02
RECRUITING
Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial CancerNCT05974995 · 2023-09-01
RECRUITING
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated TumorsNCT05313191 · 2022-01-24
RECRUITING
Avera Cancer Sequencing and Analytics Protocol (ASAP)NCT05142033 · 2021-11-01
RECRUITING
Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast CancerNCT04530890 · 2021-03-08
RECRUITING
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible SensitivityNCT04273061 · 2020-06-17
RECRUITING
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNCT04075305 · 2019-02-01
RECRUITING
Development of Clinical and Biological DatabaseNCT03449264 · 2017-07-27
RECRUITING
Food-related Quality of Life in Patients With CancerNCT07437326 · 2026-03-01
NOT_YET_RECRUITING
Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer PatientsNCT07173101 · 2025-11-07
TERMINATED
Somesthesia in Cancer Patients: Variability and Influence on Eating ExperienceNCT06803381 · 2025-03-13
NOT_YET_RECRUITING
Lung Ultrasound in Critically Ill Obstetrics and Gynecological PatientsNCT06728709 · 2024-12-15
COMPLETED
Diet, Hepcidin, and Chemotherapy RDINCT06483997 · 2024-08-16
ACTIVE_NOT_RECRUITING
Evaluation of Hydroxychloroquine to Prevent CIPNNCT05689359 · 2024-06-01
WITHDRAWN
Psychosexual Educational Partners Program (PEPP)NCT06253182 · 2024-04-02
ACTIVE_NOT_RECRUITING
Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive InterventionNCT06168825 · 2024-01-17
COMPLETED
The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support PersonNCT05509751 · 2023-10-01
ACTIVE_NOT_RECRUITING
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid TumorsNCT05961111 · 2023-06-24
UNKNOWN
Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid TumorsNCT05902520 · 2023-06-19
ACTIVE_NOT_RECRUITING
Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) InterventionNCT05677048 · 2023-04-14
ACTIVE_NOT_RECRUITING
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsNCT05704985 · 2023-04-03
ACTIVE_NOT_RECRUITING
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid TumorsNCT05860374 · 2023-03-02
UNKNOWN
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRsNCT05292859 · 2023-03-01
COMPLETED
Implementation of a Multimodal Prehabilitation Program in Robotic Oncological SurgeryNCT05671094 · 2023-01-13
COMPLETED
Clinical Investigation of the da Vinci Surgical SystemNCT05682742 · 2022-12-12
ACTIVE_NOT_RECRUITING
Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)NCT05629065 · 2022-11-28
ACTIVE_NOT_RECRUITING
Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal CarcinomatosisNCT05185947 · 2022-10-13
COMPLETED
A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler HeadsNCT05365243 · 2022-08-15
WITHDRAWN
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsNCT05131815 · 2022-07-25
COMPLETED
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid TumorsNCT05194735 · 2022-04-04
TERMINATED
Developing a Psychosexual Educational Partners Program: PEPP A Feasibility StudyNCT05070299 · 2022-03-15
COMPLETED
CAncer, NUtrition and Taste 2NCT05027490 · 2022-01-27
COMPLETED
Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer CenterNCT05065944 · 2021-11-16
COMPLETED
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsNCT05068180 · 2021-10-05
UNKNOWN
Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or HypnotherapyNCT04899492 · 2021-09-29
TERMINATED
Opening the Conversation StudyNCT04806724 · 2021-09-01
COMPLETED
Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional CounselingNCT05132868 · 2021-05-25
COMPLETED
Improving Cancer Outcomes Through Personalized Care Planning and Symptom Management.NCT04772118 · 2021-02-16
COMPLETED
Effectiveness of Wound Drains for the Prevention Of Surgical sITe infectIONNCT05179122 · 2021-01-01
COMPLETED
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer PatientsNCT04604158 · 2020-12-02
COMPLETED
A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsNCT04682431 · 2020-11-10
TERMINATED
A Study of PY314 in Subjects With Advanced Solid TumorsNCT04691375 · 2020-10-29
TERMINATED
poStoperative Anesthesia Care: Facial Mask vs Hfnc and Thoracic Ultrasound for Reduction of Atelectasis IncidenceNCT04566419 · 2020-10-01
COMPLETED
Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized TrialNCT04534075 · 2020-09-02
COMPLETED
Patient-Centered Intervention to Reduce Cancer Patients' Financial ToxicityNCT04314284 · 2020-05-26
COMPLETED
Impact of the COVID-19 Pandemic in Gynecological OncologyNCT04351139 · 2020-05-06
COMPLETED
Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in MalignanciesNCT05170087 · 2020-03-02
UNKNOWN

Common interventions

Leading sponsors

Trial status mix

COMPLETED37
RECRUITING21
ACTIVE_NOT_RECRUITING9
TERMINATED6
UNKNOWN6
WITHDRAWN3
NOT_YET_RECRUITING2

Phase mix

NA45
PHASE18
PHASE28
PHASE33
EARLY_PHASE12
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.